Authors

• Milton Packer
• Brian Lee Claggett (ORCID: https://orcid.org/0000-0002-4215-9218)
• Pardeep S. Jhund (ORCID: https://orcid.org/0000-0003-4306-5317)
• John J.V. McMurray (ORCID: https://orcid.org/0000-0002-6317-3975)
• Michael R. Zile (ORCID: https://orcid.org/0000-0001-7076-221X)
• Scott David Solomon (ORCID: https://orcid.org/0000-0003-3698-9597)
• Muthiah Vaduganathan (ORCID: https://orcid.org/0000-0003-0885-1953)
• Henri Lu (ORCID: https://orcid.org/0000-0002-9074-6505)
• Marty Lefkowitz (ORCID: https://orcid.org/0000-0002-8830-6316)
• Akshay S. Desai (ORCID: https://orcid.org/0000-0002-1443-0701)
• Carolyn Lam
• Marc A. Pfeffer

Institutions

• Brigham and Women's Hospital (US)
• Novartis (Switzerland) (CH)
• Harvard University (US)
• Medical University of South Carolina (US)
• Baylor University Medical Center (US)
• British Heart Foundation (GB)
• Novartis (United States) (US)
• National Heart Centre Singapore (SG)
• University of Lausanne (CH)

Publication Details

Journal

European Journal of Heart Failure

Published

2024-09-01

DOI

https://doi.org/10.1002/ejhf.3414

Citations

3

Primary Topic

Erythropoietin and Anemia Treatment

Type

article

Field-Weighted Citation Impact

1.36